 |
 |
|||||
 |
 |
 |
 |
 |
 |
|
Based
in Grenoble, France, PX’Therapeutics is a Contract Research and Manufacturing
Organization dedicated to the development of biotherapeutics from early
stage research up to cGMP production.
Through its specialized technology and manufacturing platforms Protein’eXpert, PX’Monoclonals and PX’Pharma, PX’Therapeutics represents the ideal partner for biotech and pharmaceutical companies to provide protein expertise all along the preclinical and clinical development of their therapeutic candidates.
• Nov 09.
PX’Therapeutics to open a new cGMP biomanufacturing facility
• May 09. PX’Therapeutics to provide Mymetics Corporation (USA/Switzerland) specific know-how for the production of a recombinant protein key in a novel preventive vaccine against HIV/AIDS.
• September 08. Protein’eXpert Changes Its Name to PX’Therapeutics in order to highlight its focus on integrated biotherapeutics development
• May 09. PX’Therapeutics to provide Mymetics Corporation (USA/Switzerland) specific know-how for the production of a recombinant protein key in a novel preventive vaccine against HIV/AIDS.
• September 08. Protein’eXpert Changes Its Name to PX’Therapeutics in order to highlight its focus on integrated biotherapeutics development
|
|
|
|
|
| Protein’eXpert offers recombinant protein engineering, feasibility study, process development and small scale production services. | |
PX’Monoclonals proposes services ranging from the generation of murine mAbs to the development of humanized antibodies for therapeutic use. | |
PX’Pharma provides dedicated contract services for process scale-up, preclinical and clinical cGMP production as well as analytical methods development. |
Zone Minatec Entreprises - 7 parvis Louis Néel - BP50 F 38040 Grenoble
Phone: +33(0)438 023 650 - Fax: +33(0)438 961 038
Phone: +33(0)438 023 650 - Fax: +33(0)438 961 038